Heron Therapeuti Stock Analysis
| HRTX Stock | USD 1.19 0.03 2.59% |
Heron Therapeuti is fairly valued with Real Value of 1.17 and Target Price of 7.3. The main objective of Heron Therapeuti stock analysis is to determine its intrinsic value, which is an estimate of what Heron Therapeuti is worth, separate from its market price. There are two main types of Heron Therapeuti's stock analysis: fundamental analysis and technical analysis.
The Heron Therapeuti stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Heron Therapeuti is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Heron Stock trading window is adjusted to America/New York timezone.
Heron |
Heron Stock Analysis Notes
About 82.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Heron Therapeuti had not issued any dividends in recent years. The entity had 1:20 split on the 13th of January 2014. Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Heron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 302 people. To learn more about Heron Therapeuti call Barry PharmD at 858 251 4400 or check out https://www.herontx.com.Heron Therapeuti Investment Alerts
| Heron Therapeuti generated a negative expected return over the last 90 days | |
| Heron Therapeuti has high historical volatility and very poor performance | |
| Heron Therapeuti may become a speculative penny stock | |
| Heron Therapeuti has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 127.04 M. Net Loss for the year was (110.56 M) with loss before overhead, payroll, taxes, and interest of (50.51 M). | |
| Heron Therapeuti currently holds about 83.54 M in cash with (58.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Heron Therapeutics, Inc. Short Interest Down 6.0 percent in October |
Heron Therapeuti Upcoming and Recent Events
Earnings reports are used by Heron Therapeuti to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Heron Largest EPS Surprises
Earnings surprises can significantly impact Heron Therapeuti's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-06 | 2024-06-30 | -0.04 | -0.06 | -0.02 | 50 | ||
2022-08-09 | 2022-06-30 | -0.5 | -0.55 | -0.05 | 10 | ||
2024-05-07 | 2024-03-31 | -0.09 | -0.02 | 0.07 | 77 |
Heron Therapeuti Thematic Classifications
In addition to having Heron Therapeuti stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
Heron Stock Institutional Investors
| Shares | Clearline Capital Lp | 2024-09-30 | 2.2 M | Renaissance Technologies Corp | 2024-09-30 | 2 M | Orchard Capital Management, Llc | 2024-09-30 | 2 M | Congress Park Capital Llc | 2024-09-30 | 2 M | Tang Capital Management Llc | 2024-09-30 | 1.9 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 1.8 M | Marshall Wace Asset Management Ltd | 2024-09-30 | 1.7 M | Goldman Sachs Group Inc | 2024-09-30 | 1.7 M | Monaco Asset Management | 2024-09-30 | 1.7 M | Rubric Capital Management Lp | 2024-09-30 | 26.7 M | Adage Capital Partners Gp Llc | 2024-09-30 | 8.8 M |
Heron Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 180.99 M.Heron Profitablity
The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.50) | (0.52) | |
| Return On Capital Employed | (0.77) | (0.81) | |
| Return On Assets | (0.50) | (0.52) | |
| Return On Equity | 3.25 | 3.42 |
Management Efficiency
Heron Therapeuti has return on total asset (ROA) of (0.0231) % which means that it has lost $0.0231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (24.0888) %, meaning that it created substantial loss on money invested by shareholders. Heron Therapeuti's management efficiency ratios could be used to measure how well Heron Therapeuti manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 3.42 in 2024, whereas Return On Tangible Assets are likely to drop (0.52) in 2024. At this time, Heron Therapeuti's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 35.4 M in 2024, whereas Other Current Assets are likely to drop slightly above 5.5 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.25) | (0.23) | |
| Tangible Book Value Per Share | (0.25) | (0.23) | |
| Enterprise Value Over EBITDA | (3.72) | (3.90) | |
| Price Book Value Ratio | (6.91) | (6.57) | |
| Enterprise Value Multiple | (3.72) | (3.90) | |
| Price Fair Value | (6.91) | (6.57) | |
| Enterprise Value | 871.2 M | 914.8 M |
Understanding the operational decisions made by Heron Therapeuti management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin (0.14) | Profit Margin (0.20) | Beta 1.809 | Return On Assets (0.02) | Return On Equity (24.09) |
Technical Drivers
As of the 2nd of December, Heron Therapeuti retains the Market Risk Adjusted Performance of (0.29), risk adjusted performance of (0.08), and Standard Deviation of 5.09. Heron Therapeuti technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Heron Therapeuti Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Heron Therapeuti middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Heron Therapeuti. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Heron Therapeuti Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heron Therapeuti insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heron Therapeuti's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heron Therapeuti insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Heron Therapeuti Outstanding Bonds
Heron Therapeuti issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heron Therapeuti uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heron bonds can be classified according to their maturity, which is the date when Heron Therapeuti has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Heron Therapeuti Predictive Daily Indicators
Heron Therapeuti intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heron Therapeuti stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Heron Therapeuti Forecast Models
Heron Therapeuti's time-series forecasting models are one of many Heron Therapeuti's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heron Therapeuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Heron Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Heron Therapeuti prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heron Therapeuti. By using and applying Heron Stock analysis, traders can create a robust methodology for identifying Heron entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.87) | (0.91) | |
| Operating Profit Margin | (0.87) | (0.91) | |
| Net Loss | (0.87) | (0.91) | |
| Gross Profit Margin | 0.49 | 0.51 |
Current Heron Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 7.3 | Strong Buy | 3 | Odds |
Most Heron analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Heron stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Heron Therapeuti, talking to its executives and customers, or listening to Heron conference calls.
Heron Stock Analysis Indicators
Heron Therapeuti stock analysis indicators help investors evaluate how Heron Therapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heron Therapeuti shares will generate the highest return on investment. By understating and applying Heron Therapeuti stock analysis, traders can identify Heron Therapeuti position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 15.4 M | |
| Long Term Debt | 173.8 M | |
| Common Stock Shares Outstanding | 138.1 M | |
| Total Stockholder Equity | -34 M | |
| Property Plant And Equipment Net | 25.6 M | |
| Cash And Short Term Investments | 80.4 M | |
| Cash | 28.7 M | |
| Accounts Payable | 3.2 M | |
| Net Debt | 151 M | |
| 50 Day M A | 1.6898 | |
| Total Current Liabilities | 79.7 M | |
| Other Operating Expenses | 237.7 M | |
| Non Current Assets Total | 33.7 M | |
| Non Currrent Assets Other | 8.1 M | |
| Stock Based Compensation | 32.9 M |
Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.